Cutting edge:: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

被引:926
作者
Fantini, MC
Becker, C
Monteleone, G
Pallone, F
Galle, PR
Neurath, MF
机构
[1] Johannes Gutenberg Univ Mainz, Immunol Lab, Med Clin 1, D-55131 Mainz, Germany
[2] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy
关键词
D O I
10.4049/jimmunol.172.9.5149
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) CD25(+) regulatory cells are a subpopulation of T lymphoiytes of thymic origin. However, recent data suggest an alternative commitment of regulatory T cells in the periphery, although the precise mechanism is unknown. In the present work, we demonstrate that TGF-beta is able to induce Toxp3 expression and subsequently a regulatory phenotype in CD4(+) CD25(-) peripheral murine T cells. Similarly, TGF-beta induced Foxp3 in human CD4(+) CD25(-) T cells. Moreover, we show that the inhibitory Smad7 protein that is normally induced by TGF-9 and limits TGF-beta signaling, is strongly down-regulated by Foxp3 at the transcriptional level. Foxy3-mediated down-regulation of Smad7 subsequently rendered CD4+ CD25- T cells highly susceptible to the morphogenic and regulatory effects of TGF-beta signaling via Smad3/4. In summary, we demonstrate that TGF-beta induces a regulatory phenotype in CD4(+) CD25(-) T cells through the induction of Toxp3 and a positive autoregulatory loop of TGF-beta signaling due to the absence of Smad7.
引用
收藏
页码:5149 / 5153
页数:5
相关论文
共 14 条
  • [11] CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness
    Piccirillo, CA
    Letterio, JJ
    Thornton, AM
    McHugh, RS
    Mamura, M
    Mizuhara, H
    Shevach, EM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (02) : 237 - 245
  • [12] Mechanisms of TGF-β signaling from cell membrane to the nucleus
    Shi, YG
    Massagué, J
    [J]. CELL, 2003, 113 (06) : 685 - 700
  • [13] CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
    Tiede, I
    Fritz, G
    Strand, S
    Poppe, D
    Dvorsky, R
    Strand, D
    Lehr, HA
    Wirtz, S
    Becker, C
    Atreya, R
    Mudter, J
    Hildner, K
    Bartsch, B
    Holtmann, M
    Blumberg, R
    Walczak, H
    Iven, H
    Galle, PR
    Ahmadian, MR
    Neurath, MF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (08) : 1133 - 1145
  • [14] Activation of CD25+CD4+ regulatory T cells by oral antigen administration
    Zhang, XM
    Izikson, L
    Liu, LM
    Weiner, HL
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (08) : 4245 - 4253